All Posts

Pharma News for Amgen, Anaptys, Sanofi, Boehringer
Amgen to Acquire Horizon Therapeutics; Sanofi and Teva Announce Collaboration; Boehringer Obesity Drug Trial Update; FDA Places Partial Clinical Hold on IND for Lacutamab in CTCL/PTCL; Anaptys Announces Phase 3 Clinical Trial Results of Imsidolimab; Orphan Drug Designation to GC Biopharma’s GC1126A

Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment Sanofi and Teva Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries Ltd. in the United States, have announced a collaboration to co-develop and co-commercialize asset TEV'574, which is currently in Phase ...

Find More

primary-hyperoxaluria-treatment
Can Novo’s Rivfloza Outperform Its Rival Alnylam’s Oxlumo in Primary Hyperoxaluria Treatment Space?

In recent years, Novo Nordisk has been actively addressing the challenges arising from the launch of its highly popular obesity therapy, Wegovy. However, the pharmaceutical company is now venturing into a less common medical territory with its latest FDA approval. Novo has received FDA approval for Rivfloza, a trea...

Find More

tackling-nausea-and-vomiting-induced-by-motion-sickness
Tackling Nausea and Vomiting Induced by Motion Sickness

There has been an unprecedented explosion in travel in recent years as a result of greater affordability and opportunities. Comfort has become an important element of travel with products such as pillows, eyeshades, and noise-cancelling headphones promising better sleep and reduced stress. Despite these, some peopl...

Find More

MedTech News for Boston Scientific, Enable Injections
Boston Scientific’s Insertable Cardiac Monitor; Phillips-Medisize Teamed up with GlucoModicum; Boston Scientific’s Intravascular Ultrasound System; Enable Injections Received First US FDA Approval; Amber Implants’s VCFix® Spinal System; Loci Orthopaedics’s “InDx” Thumb Base Joint Replacement Study

Boston Scientific Launched Next-Generation Insertable Cardiac Monitor On October 2, 2023, Boston Scientific, announced the launch of its next-generation LUX-Dx II+ insertable cardiac monitor (ICM) system.  Long-term monitoring is provided by the system for arrhythmias connected to conditions like AFib, c...

Find More

Alzheimer’s Disease Diagnostic Market Analysis
Alzheimer’s Disease Diagnostic: Market Dynamics, Key Trends, and Growth Potential

Alzheimer’s Disease represents one of the most pressing challenges in today's healthcare market. As its prevalence continues to soar with the aging global population, the hurdles in its diagnostic and treatment also continue to rise. As per the estimate, globally, about 55 million people are living with dementia in...

Find More

Pharma News for AbbVie, Novartis, Avenge Bio, Eli Lilly
AbbVie Presents Phase III CANOVA Study Results; Novartis’ Iptacopan Shows Promise in Phase III Study; Fast Track Designation to AVB-001 for R/R Platinum-Resistant Ovarian Cancer; FDA Issues Complete Response Letter for Lebrikizumab; Nedosiran Approveed for Primary Hyperoxaluria Type 1; Orphan Drug Designation to BDC-1001 for Gastric Cancers

AbbVie Presents Results from Phase III CANOVA Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma AbbVie has released findings from its Phase III CANOVA trial, which assessed the safety and effectiveness of venetoclax (marketed as VENCLEXTA®/VENCLYXTO®) in combination with dexamethasone ...

Find More

MedTech News for Orthofix, Medtronic, MicroVention
Orthofix Launched the Galaxy Fixation Gemini System; Oxford Biodynamics Launched the EpiSwitch Prostate Screening Blood Test; CE Mark for the Medtronic’s New Simplera CGM; FDA 510(k) Clearance to MicroVention’s SOFIA™ EX 5F 115cm; SHL Telemedicine’s SmartHeart® Technology; Cardiosense’s Nationwide Heart Failure Study

Orthofix Launched the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures On September 20, 2023, Orthofix Medical Inc., a leading global spine and orthopedics company, launched the Galaxy Fixation Gemini™ system.  It is a stable external fixation system that ...

Find More

alzheimers-disease-treatment-drug-clinical-trial-failures
Challenges in the Pursuit of Alzheimer’s Disease Treatment Breakthroughs: Drug Clinical Trial Failures

Alzheimer’s, the most common type of dementia, particularly with an increasing geriatric population, presents a major global crisis. The disease mostly occurs in sexagenarians, but it may manifest in quadragenarians. It is one of the most prevalent neurodegenerative disorders with a multifactorial pathogenesis. It ...

Find More

netherton-syndrome-treatment
Netherton Syndrome: Unraveling the Uncertainties of a Rare Genetic Skin Disorder

Quick Facts about Netherton Syndrome Netherton syndrome, a less common form of ichthyosis, is a monogenic cutaneous condition characterized by congenital scaly erythroderma, evolving into typical erythematous patches with peripheral scaling, hair shaft abnormalities, and atopic manifestation. Netherton syndr...

Find More

Smart Medical Devices Market Outlook
The Revolution of Healthcare: Smart Medical Devices Transforming the Future

It is not surprising that the healthcare sector is undergoing a significant transition in an era characterized by technological developments and the digitization of almost every aspect of our lives. The development of smart medical devices is a shining illustration of how technology has advanced in healthcare in a ...

Find More